Dutasteride for trans men? (Topical vs oral?) Transgender 10/29/2024
The conversation discusses using dutasteride, both topical and oral, for hair loss in trans men, considering potential side effects like depression and libido issues. The user is exploring options including topical solutions with minoxidil, retinoic acid, and hydrocortisone, and plans to start microneedling.
View this post in the Community ā
Similar Community Posts Join
5 / 5 resultscommunity 5 months dutasteride and minoxidil. Went from NW3 with diffuse thinning and retrograde alopecia to a dense NW2. See
A user achieved significant hair regrowth from Norwood 3 to a dense Norwood 2 after five months using oral dutasteride, oral minoxidil, and a topical solution with minoxidil, retinoic acid, and hydrocortisone. The user reported no side effects and found the topical treatment especially effective for the hairline.
community Update: 9 months of oral Dutasteride & topical Minoxidil has done more than I ever expected
Oral Dutasteride and topical Minoxidil significantly improved hair regrowth over nine months. Other users shared mixed results and side effects with treatments like oral Minoxidil and Finasteride.
community Results from oral treatment vs topical
The conversation discusses switching from oral to topical treatments for hair loss, specifically using a mix of retinoic acid, finasteride, and minoxidil, after oral treatments like dutasteride and finasteride were ineffective. The user is concerned about the cost and potential impact of dandruff on the absorption of topical treatments.
community topical cetirizine to control scalp inflammation
The user applies a topical solution containing minoxidil, finasteride, dutasteride, retinoic acid, and hydrocortisone to address scalp inflammation and is considering adding cetirizine to the mix. They are calculating the correct amount of cetirizine to add to their formula and have paused this approach to retry oral minoxidil.
community 3 months minoxidil, 2.5 months finasteride, 1.5 months topical dutasteride. Iām starting to get really happy about my results and I am noticing in improvements each week. It is getting much fuller in the front. I think Iām going to be a hyper responder. Read the description for my stack.(22M)
The user experienced significant hair regrowth using oral minoxidil, finasteride, and topical dutasteride, with no side effects. They plan to continue these treatments long-term to maintain results.
Related Research
6 / 6 results
research Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
This study reported that while no effective treatment exists for frontal fibrosing alopecia, oral 5-alpha-reductase inhibitors showed the most promise, inducing a good clinical response in 45% of patients.
research Lichen Planopilaris in Women
In this study, women with lichen planopilaris were found to have high rates of thyroid disease, depression, and anxiety, and about half experienced slowed or stabilized disease progression with treatment.
research Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia
research Epidemiologic Study of Gene Distribution in Romanian and Brazilian Patients with Non-Cicatricial Alopecia
In this study, DNA analysis of patients with androgenetic alopecia and alopecia areata indicated potential differences in treatment response based on genetic makeup across Romanian and Brazilian populations, notably involving genes like GR-alpha and SULT1A1, which may guide personalized treatment strategies.
research Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
This review provides a detailed overview of the causes, prevalence, pathophysiology, clinical presentation, and treatment of beard alopecia, highlighting conditions such as alopecia areata, pseudofolliculitis barbae, and tinea barbae, and aims to serve as a resource for clinicians handling such cases.
research Emerging treatments in alopecia
This review discusses emerging treatments and mechanisms for alopecia, highlighting potential therapies like janus kinase inhibitors and advances in stem-cell technology, but reports no new experimental results.